Gatifloxacin-induced dysglycemia

American Journal of Health-System Pharmacy

Volumn 63, Issue 21, 2006, Pages 2087-2092

  Zvonar, Rosemary ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antidiabetic agents; Caloric agents; Dextrose; Diabetes mellitus; Gatifloxacin; Geriatrics; Hyperglycemic; Hypoglycemia; Insulin; Kidney failure; Mechanism of action; Quinolones; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATE; AMITRIPTYLINE; AMLODIPINE; ANASTROZOLE; CIPROFLOXACIN; CREATININE; FOSINOPRIL; FUROSEMIDE; GABAPENTIN; GATIFLOXACIN; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; HYDROCHLOROTHIAZIDE; INSULIN; IPRATROPIUM BROMIDE; ISOPHANE INSULIN; LORAZEPAM; METFORMIN; MEVINOLIN; MORPHINE; ORAL ANTIDIABETIC AGENT; PANTOPRAZOLE; POTASSIUM CHANNEL; PREDNISONE; SALBUTAMOL; UNINDEXED DRUG; WARFARIN;

AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DISORIENTATION; DRUG WITHDRAWAL; DYSGLYCEMIA; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INSULIN RELEASE; KIDNEY DYSFUNCTION; MALE; PANCREAS ISLET BETA CELL; PNEUMONIA; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROBABILITY; RATING SCALE; SEIZURE; STRESS;

EID: 33751052957     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060024     Document Type: Article

References (38)

1. Tequin (gatifloxacin) product monograph (revised). Montreal, Quebec: Bristol-Myers Squibb Canada Inc.; 2004 Apr.
2. Menzies DJ, Dorsainvil PA, Cunha BA et al. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. Am J Med. 2002; 113:232-4.
3. Baker SE, Hangii MC. Possible gatifloxacin-induced hypoglycemia. Ann Pharmacother. 2002; 36:1722-6.
4. Parilo MA. Gatifloxacin-associated hypoglycemia. J Pharm Technol 2002; 18:319-20.
5. Hussein G, Perkins LT, Sternberg M et al. Gatifloxacin-induced hypoglycemia: a case report and review of the literature. Clin Res Regul Aff. 2002; 19:333-9.
6. LeBlanc M, Belanger C, Cossette P. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy. Pharmacotherapy. 2004; 24:926-31.
7. Biggs WS. Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients. J Am Board Fam Pract. 2003; 16:455-7.
8. Brogan SE, Cahalan MK. Gatifloxacin as a possible cause of serious postoperative hypoglycemia. Anesth Analg. 2005; 101:635-6.
9. [Erratum, Anesth Analg. 2005; 101:1614.]
10. Khovidhunkit W, Sunthornyothin S. Hypoglycemia, hyperglycemia, and gatifloxacin. Ann Intern Med. 2004; 141:969. Letter.
11. Vigneault M. L'hypoglycémie grave associée à la prise de gatifloxacine et d'une sulfonylurée. Québec Pharm. 2003; 50:757-61. In French.
12. Bhasin R, Arce FC, Pasmantier R. Hypoglycemia associated with the use of gatifloxacin. Am J Med Sci. 2005; 330:250-3.
13. Happe MR, Mulhall BP, Maydonovitch CL et al. Gatifloxacin-induced hyperglycemia. Ann Intern Med. 2004; 141:968-9. Letter.
14. Donaldson AR, Vandiver JR, Finch CK. Possible gatifloxacin-induced hyperglycemia. Ann Pharmacother. 2004; 38:602-5.
15. Arce FC, Bhasin RS, Pasmantier R. Severe hyperglycemia during gatifloxacin therapy in patients without diabetes. Endocr Pract. 2004; 10:40-4.
16. Bhatia V, Bhatia R, Dhindsa S. Gatifloxacin-induced hyperglycemia. Endocr Pract. 2004; 10:86. Letter.
17. Blommel AL, Lutes RA. Severe hyperglycemia during renally adjusted gatifloxacin therapy. Ann Pharmacother. 2005; 39:1349-52.
18. Stading JA, Chock AW, Skrabal MZ et al. Development of diabetes after gatifloxacin therapy. Am J Health-Syst Pharm. 2005; 62:2293-5.
19. Tequin (gatifloxacin) prescribing information (revised). Princeton, NJ: Bristol-Myers Squibb; 2006 Jan.
20. Health Canada. Advisory: Health Canada advises diabetic patients not to use the antibiotic Tequin. www.hc-sc.gc. ca/ahc-asc/media/advisories-avis/2006/ 2006_09_e.html (accessed 2006 Mar 21).
21. Thompson CA. Tequin to exit markets worldwide. www.ashp.org/news/ showArticle.cfm?id=15156 (accessed 2006 Jun 23).
22. Levaquin (levofloxacin) product monograph (revised). Toronto, Ontario: Janssen-Ortho Inc.; 2004 Feb.
23. Avelox (moxifloxacin hydrochloride) product monograph (revised). Toronto, Ontario: Bayer Inc.; 2004 Jan.
24. Roberge RJ, Kaplan R, Frank R et al. Glyburide-ciprofloxacin interaction with resistant hypoglycemia. Ann Emerg Med. 2000; 36:160-3.
25. Garon N, Cloutier I. Une hypoglycémie associée à la levofloxacine (Levaquin). Quebec Pharm. 2001; 48:71-4. In French.
26. Friedrich LV, Dougherty R. Fatal hypoglycemia associated with levofloxacin. Pharmacotherapy. 2004; 24:1807-12.
27. Letourneau G, Morrison H, McMorran M. Gatifloxacin (Tequin): hypoglycemia and hyperglycemia. Can Adverse Reaction Newsl. 2003; 13(3):1.
28. Frothingham R. Glucose homeostasis abnormalities associated with use of gatifloxacin. Clin Infect Dis. 2005; 41:1269-76.
29. Maeda N, Tamagawa T, Niki I et al. Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br J Pharmacol. 1996; 117:372-6.
30. + channels. Eur J Pharmacol. 2004; 497:111-7.
31. + channels. Life Sci. 2003; 73:429-35.
32. Afifi NA. Effect of antibacterial quinolones on blood glucose level of normal and hyperglycaemic rats and their interactions with glibenclamide. J Drug Res. 1990; 19:189-97.
33. Ambrose PG, Bhavnani SM, Cirincione BB et al. Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction. J Antimicrob Chemother. 2003; 52:435-40.
34. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
35. Graumlich JF, Habis S, Avelino RR et al. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study. Pharmacotherapy. 2005; 25:1296-302.
36. Mohr JF, McKinnon PS, Peymann PJ et al. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin or ceftriaxone. Pharmacotherapy. 2005; 25:1303-9.
37. Coblio NA, Mowrey K, McCright P et al. Use of a data warehouse to examine the effect of fluoroquinolones on glucose metabolism. Am J Health-Syst Pharm. 2004; 61:2545-8.
38. Park-Wyllie LY, Juurlink DN, Kopp A et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med. 2006; 354:1352-61.